The SIDER Database of Drugs and Side Effects

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2015 Oct 21

PMID 26481350

Citations 416

Authors

Michael Kuhn

Ivica Letunic

Lars Juhl Jensen

Peer Bork

Affiliations

Soon will be listed here.

Abstract

Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.

Citing Articles

Hepatotoxicity Evaluation of Levornidazole and Its Three Main Impurities: Based on Structure-Toxicity Classification Prediction Combined with Zebrafish Toxicity Assessment.

Liu T, Yuan S, Zhang L, Zhang D Molecules. 2025; 30(5).

PMID: 40076220 PMC: 11901814. DOI: 10.3390/molecules30050995.

An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results.

Yazdani A, Bornet A, Khlebnikov P, Zhang B, Rouhizadeh H, Amini P Sci Data. 2025; 12(1):424.

PMID: 40069213 PMC: 11897206. DOI: 10.1038/s41597-025-04718-1.

Integrating convolutional layers and biformer network with forward-forward and backpropagation training.

Kianfar A, Razzaghi P, Asgari Z Sci Rep. 2025; 15(1):7230.

PMID: 40021838 PMC: 11871031. DOI: 10.1038/s41598-025-92218-y.

Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabel.

Wu L, Fang H, Qu Y, Xu J, Tong W Drug Saf. 2025; .

PMID: 39979771 DOI: 10.1007/s40264-025-01520-1.

Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle.

Nair G, Saraswathy G, Aranjani J, Ibrahim R Sci Rep. 2025; 15(1):4979.

PMID: 39929880 PMC: 11811192. DOI: 10.1038/s41598-025-87676-3.

References

Kuhn M, Al Banchaabouchi M, Campillos M, Jensen L, Gross C, Gavin A . Systematic identification of proteins that elicit drug side effects. Mol Syst Biol. 2013; 9:663. PMC: 3693830. DOI: 10.1038/msb.2013.10. View

Zielinski D, Filipp F, Bordbar A, Jensen K, Smith J, Herrgard M . Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis. Nat Commun. 2015; 6:7101. PMC: 4468904. DOI: 10.1038/ncomms8101. View

Gurulingappa H, Mateen-Rajput A, Toldo L . Extraction of potential adverse drug events from medical case reports. J Biomed Semantics. 2012; 3(1):15. PMC: 3599676. DOI: 10.1186/2041-1480-3-15. View

Kuhn M, Campillos M, Letunic I, Jensen L, Bork P . A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol. 2010; 6:343. PMC: 2824526. DOI: 10.1038/msb.2009.98. View

Pafilis E, Frankild S, Fanini L, Faulwetter S, Pavloudi C, Vasileiadou A . The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text. PLoS One. 2013; 8(6):e65390. PMC: 3688812. DOI: 10.1371/journal.pone.0065390. View

Gottlieb A, Stein G, Ruppin E, Sharan R . PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011; 7:496. PMC: 3159979. DOI: 10.1038/msb.2011.26. View

Duran-Frigola M, Aloy P . Analysis of chemical and biological features yields mechanistic insights into drug side effects. Chem Biol. 2013; 20(4):594-603. DOI: 10.1016/j.chembiol.2013.03.017. View

Yeleswarapu S, Rao A, Joseph T, Saipradeep V, Srinivasan R . A pipeline to extract drug-adverse event pairs from multiple data sources. BMC Med Inform Decis Mak. 2014; 14:13. PMC: 3936866. DOI: 10.1186/1472-6947-14-13. View

Xu R, Wang Q . Automatic construction of a large-scale and accurate drug-side-effect association knowledge base from biomedical literature. J Biomed Inform. 2014; 51:191-9. PMC: 4589180. DOI: 10.1016/j.jbi.2014.05.013. View

10.

Cai M, Xu Q, Pan Y, Pan W, Ji N, Li Y . ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms. Nucleic Acids Res. 2014; 43(Database issue):D907-13. PMC: 4383906. DOI: 10.1093/nar/gku1066. View

11.

Kuhn M, Szklarczyk D, Pletscher-Frankild S, Blicher T, von Mering C, Jensen L . STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res. 2013; 42(Database issue):D401-7. PMC: 3964996. DOI: 10.1093/nar/gkt1207. View

12.

Eriksson R, Werge T, Jensen L, Brunak S . Dose-specific adverse drug reaction identification in electronic patient records: temporal data mining in an inpatient psychiatric population. Drug Saf. 2014; 37(4):237-47. PMC: 3975083. DOI: 10.1007/s40264-014-0145-z. View

13.

Juan-Blanco T, Duran-Frigola M, Aloy P . IntSide: a web server for the chemical and biological examination of drug side effects. Bioinformatics. 2014; 31(4):612-3. DOI: 10.1093/bioinformatics/btu688. View

14.

Liu T, Altman R . Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach. J Chem Inf Model. 2015; 55(7):1483-94. PMC: 4875781. DOI: 10.1021/acs.jcim.5b00030. View

15.

Pafilis E, ODonoghue S, Jensen L, Horn H, Kuhn M, Brown N . Reflect: augmented browsing for the life scientist. Nat Biotechnol. 2009; 27(6):508-10. DOI: 10.1038/nbt0609-508. View

16.

Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A . STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2012; 41(Database issue):D808-15. PMC: 3531103. DOI: 10.1093/nar/gks1094. View

17.

Campillos M, Kuhn M, Gavin A, Jensen L, Bork P . Drug target identification using side-effect similarity. Science. 2008; 321(5886):263-6. DOI: 10.1126/science.1158140. View